ReviewSurgical endoscopy2011
Percutaneous treatment of thoracic duct injuries.
Review in Surgical endoscopy, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Risk of chyle leak after robotic versus video-assisted thoracoscopic esophagectomy.Surgical endoscopy · 2022Article
- Embolization or disruption of thoracic duct and cisterna chyli leaks post oesophageal cancer surgery should be first line management for ECCG-defined type III chyle fistulae.Irish journal of medical science · 2021Article
- Traumatic chylothorax: a dilemma to surgeons and interventionists.BMJ case reports · 2021Article
- Clinical manifestation, risk factors and managements for postoperative chylothorax after thoracic esophagectomy.Journal of thoracic disease · 2019Article
- Chlyous leak after radical oesophagectomy: Thoracic duct lymphangiography and embolisation (TDE)-A case report.International journal of surgery case reports · 2016Article
- Chyle leakage patterns and management after oncologic esophagectomy: A retrospective cohort study.Thoracic cancer · 2014Article
- Idiopathic chylothorax in a young man.BMJ case reports · 2012Article
- Non-Hodgkin's Lymphoma as a Risk Factor for Persistent Chylothorax After Transhiatal Esophagectomy.World journal of oncology · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMajor thoracic or neck surgery or penetrating trauma can cause injury to the thoracic duct and development of a chylothorax. Chylothorax results in metabolic and immunologic disorders that can be life threatening, with a mortality rate reaching 50%. The management of chyle leaks is dependent on the etiology and daily output. Interventions are used to treat only leaks unresponsive to medical management or those with an output exceeding 1,000 ml/day.
methodsThis study reviewed the existing literature on the percutaneous management of chyle leaks. The authors evaluated five case series and three case reports inclusive of 90 patients in which percutaneous treatment for chylothorax was attempted between 1998 and 2004.
resultsFor 71 patients, percutaneous treatment was technically successful, and chylothorax resolved in 49 of the patients (69%). Percutaneous treatment of chylothorax was associated with a 2% morbidity rate and no mortality. For 19 patients whose percutaneous approach failed, either surgical ligation or pleurodesis was performed.
conclusionsThe percutaneous management of chyle leak is feasible, with low morbidity and mortality rates and a high rate of effectiveness. This approach should be considered before more invasive procedures.
Indexed as
Identifiers
21584855What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.